All In MedTech

Device Trial Radar · NCT03381248

Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain

A Prospective, Multi-center, Randomized, Clinical Trial Evaluating the Safety and Effectiveness of Using COOLIEF™ Cooled Radiofrequency Probe to Create Lesions of the Genicular Nerves and Comparing a Single Injection of Hyaluronic Acid in the Management of Knee Pain

Last checked: Nov 20, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 177 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

177

Actual

Start

Dec 7, 2017

Primary completion

Feb 8, 2019

Study completion Jul 20, 2020

Sponsor

Lead sponsor
Avanos MedicalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 21, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, randomized, multicenter comparison study examining the outcomes of subjects with osteoarthritis and knee pain undergoing a procedure to create a radiofrequency lesion of the genicular nerves with the Cooled Radiofrequency Ablation (CRFA) system compared to subjects receiving Hyaluronic Acid (HA). Approximately 168 subjects will be enrolled into this study, with subjects undergoing either CRFA or HA injection in a 1:1 randomization scheme. Follow-up will be conducted for 12 months post-CRFA, with the primary endpoint being completed at month 6. Subjects randomized to the comparison (HA) group will have the option to cross-over to the neurotomy group after completing the 6-month endpoint assessment. They will be followed for an additional 6 months. Pain, overall outcome, quality of life, pain medication use, and adverse events will be compared between the two treatment groups to determine success. Subjects who were randomized to and received COOLIEF\* as their initial treatment will have the option to add 2 additional visits at 6-month intervals, representing 18 and 24 months post initial treatment.

Conditions

  • Osteoarthritis of the Knee

Interventions

  • Cooled RadiofrequencyDevice

    Delivery of energy to ablate sensory nerves via cooled radiofrequency probe.

  • Hyaluronic Acid InjectionOther

    Delivery of hyaluronic acid into knee by injection with needle to reduce knee pain.

  • Crossover from Hyaluronic Acid Injection to Cooled RadiofrequencyOther

    Delivery of hyaluronic acid into knee by injection with needle to reduce knee pain. After 6 months, qualifying subjects in this group will have the option to crossover to receive cooled radiofrequency treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Numeric Rating Scale (NRS)Time frame: Baseline to 6 month study visit

1 more outcomes with a free account

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Lyman Medical Research

    Coeur d'Alene, Idaho

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.